RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-206c8dbc558357a6GRADE VERY_LOW
stinging nettle constituents — immune
direction BENEFIT · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
3bound studies
Bound studies (3 shown of 3)
STU-4448558b1c02ebffANIMAL · ANIMAL · 2016 · RoB INSUFFICIENT_INFORMATION
1 endpoints
STU-4b30f2e4777e5769IN_VITRO · IN_VITRO · 2013 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-93ba114a34111c11UNSPECIFIED · HUMAN · 2017 · RoB NOT_ASSESSABLE
3 endpoints
Quantitative observations
observation p<0.05 · failed extraction
observation 10 · validated
observation p<0.01 · validated
Opposition screen
SCREEN · 5 candidates considered · 0 bound as opposing
SYNTHESIS SYN-696dcea5826b5e — outcome QUALITATIVE_ONLY · BENEFIT ×3 · not_assessed_quantitatively · 3 members
PROVENANCE → epmc:IND605265206, epmc:23092723, epmc:28544187 · PKG fc5f5ef3ba474877…
CLAIM · CLM-03e20ba4271dd0d1GRADE VERY_LOW
stinging nettle constituents — inflammation
direction BENEFIT · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
LOWnumeric
2bound studies
Bound studies (2 shown of 2)
STU-4b30f2e4777e5769IN_VITRO · IN_VITRO · 2013 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-93ba114a34111c11UNSPECIFIED · HUMAN · 2017 · RoB NOT_ASSESSABLE
3 endpoints
Quantitative observations
Opposition screen
SCREEN · 4 candidates considered · 2 bound as opposing
SYNTHESIS SYN-d7c0d9adb07a02 — outcome QUALITATIVE_ONLY · BENEFIT ×2 · not_assessed_quantitatively · 2 members
PROVENANCE → epmc:23092723, epmc:28544187 · PKG fc5f5ef3ba474877…
Bounded preview — representative records only. The full release ships 17 claims and 56 observations.